Jefferies Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)

August 6, 2026 9:11 AM EDT Send to a Friend
Jefferies analyst Maury Raycroft reiterated a Buy rating and $10.00 price target on Black Diamond Therapeutics (NASDAQ: BDTX).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login